Navigation Links
GEN Joins Charles Darwin 2009 Celebration
Date:1/5/2009

NEW ROCHELLE, N.Y., Jan. 5 /PRNewswire/ -- Theodosius Dobzhansky, the late great geneticist and evolutionary biologist, said it best: "Nothing in biology makes sense except in the light of evolution."

This year marks the 200th birthday of Charles Darwin (February 12, 1809) and the 150th anniversary of the publication of the Origin of Species, which laid out the theory of evolution by means of natural selection in exquisite detail. Universities, academic centers, and other scientific organizations all over the globe have a plethora of events planned to honor Darwin's contributions and legacy. Genetic Engineering and Biotechnology News (GEN) is taking part in the celebration of Darwin as well.

"If it weren't for Charles Darwin and Alfred Russel Wallace, there would probably be no biotechnology industry," says John Sterling, Editor in Chief of GEN. "Every life-science-related discipline is deeply grounded in evolutionary theory. This is particularly the case with genetics and molecular biology, two cornerstones of biotech research."

In the January 1 issue, GEN published excerpts of an interview with Sean Carroll, Ph.D., professor of molecular biology and genetics and an investigator with the Howard Hughes Medical Institute at the University of Wisconsin. Dr. Carroll's research has centered on the genes that control animal body patterns and play major roles in the evolution of animal diversity. This field of study is known as evolutionary developmental biology, or "Evo Devo." The entire interview with Dr. Carroll can be heard as a podcast at www.genengnews.com

In addition to providing his insights on the significance of Charles Darwin and the impact and importance of Evo Devo on the foundation of evolutionary theory, Dr. Carroll also discusses how research advances taking place in Evo Devo can be translated into applied biotech applications.

During each subsequent month throughout 2009, GEN will interview a leading researcher, philosopher, or theorist in evolutionary science, including many experts on Darwin. Their thoughts and insights will appear in the print version of GEN and online as podcasts. Dozens of online links to articles, videos, podcasts, commentaries, and various events and conferences around the world celebrating Charles Darwin will also be provided.

We cordially invite you to our year-long Darwin party!

For a copy of the January 1 issue of GEN, please call (914) 740-2122, or email: ebicovny@liebertpub.com

Genetic Engineering and Biotechnology News (GEN) (www.genengnews.com), which is published 21 times a year by Mary Ann Liebert, Inc., is the most widely read biotechnology news magazine worldwide. It includes articles on Drug Discovery, Bioprocessing, OMICS, Biobusiness, and Clinical Research and Diagnostics.

Contact: John Sterling, Editor in Chief, Genetic Engineering and Biotechnology News (914) 740-2196, jsterling@genengnews.com


'/>"/>
SOURCE Genetic Engineering and Biotechnology News (GEN)
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
2. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
3. Hank Plain Joins Morgenthaler Ventures as Partner
4. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
5. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
6. Dan Broderick Joins Prolog Ventures as Partner
7. Ingenuity Systems Joins Biomarkers Consortium
8. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
9. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
10. Progeniq Joins Microsoft in Bio IT Alliance
11. Jeffrey H. Buchalter Joins MacroGenics Board of Directors as Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... In today,s pre-market research, Stock-Callers.com ... Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals ... and Regulus Therapeutics Inc. (NASDAQ: RGLS ). ... its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more ... ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... regeneration from small lab samples to full-size tissues, bones, even whole organs to ... vascular system that delivers blood deep into the developing tissue. , Current ...
(Date:3/22/2017)... , March 22, 2017 Good Start Genetics, ... has eclipsed the 130 million covered lives mark through ... of Texas . With newly signed ... continues to enjoy strong payor acceptance based on the ... programs and genetic counseling, its industry-leading customer care and ...
(Date:3/22/2017)... York , March 22, 2017 ... largely fragmented, states a research report by Transparency Market ... Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted for ... 2015. The prominent players in this market are focusing ... their product portfolio, which is likely to lead to ...
Breaking Biology Technology:
(Date:3/7/2017)... 7, 2017 Brandwatch , the leading social intelligence ... Prince,s Trust to uncover insights to support its reporting, help ... The UK,s leading youth charity will be using Brandwatch Analytics ... get a better understanding of the topics and issues that are ... ...
(Date:3/2/2017)... YORK , March 2, 2017 Summary ... better understand Perrigo and its partnering interests and activities since ... ... Partnering Deals and Alliance since 2010 report provides an in-depth ... leading life sciences companies. On demand company reports ...
(Date:3/2/2017)... , March 2, 2017 Australian stem ... (ASX: CYP), has signed an agreement with the ... the Monash Biomedicine Discovery Institute and Department of Pharmacology ... conduct a further preclinical study to support the use ... of asthma.  Asthma is a chronic, ...
Breaking Biology News(10 mins):